FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Theradiag Snags CE Mark for Biotherapy Monitoring Analyzer

Nov. 22, 2019
A A

Theradiag has earned the CE Mark for its i-Track10, an automated analyzer designed for use with biotherapy monitoring devices.

The analyzer measures the efficiency of biotherapies for treating cancer and autoimmune diseases and is compatible with all biotherapy monitoring products, the company said.

The i-Track10 can be integrated into laboratory automation systems and features random access analysis and continuous loading capabilities.

View today's stories